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Abstract 
Background: Relapse and metastasis in colorectal cancer (CRC) are often attributed to cancer stem‑like cells (CSCs), 
as small sub‑population of tumor cells with ability of drug resistance. Accordingly, development of appropriate mod‑
els to investigate CSCs biology and establishment of effective therapeutic strategies is warranted. Hence, we aimed to 
assess the capability of two widely used and important colorectal cancer cell lines, HT‑29 and Caco‑2, in generating 
spheroids and their detailed morphological and molecular characteristics.
Methods: CRC spheroids were developed using hanging drop and forced floating in serum‑free and non‑attach‑
ment conditions and their morphological features were evaluated by scanning electron microscopy (SEM). Then, the 
potential of CSCs enrichment in spheroids was compared to their adherent counterparts by analysis of serial sphere 
formation capacity, real‑time PCR of key stemness genes (KLF4, OCT4, SOX2, NANOG, C-MYC) and the expression of 
potential CRC‑CSCs surface markers (CD166, CD44, and CD133) by flow cytometry. Finally, the expression level of 
some EMT‑related (Vimentin, SNAIL1, TWIST1, N-cadherin, E-cadherin, ZEB1) and multi‑drug resistant (ABCB1, ABCC1, 
ABCG2) genes was evaluated.
Results: Although with different morphological features, both cell lines were formed CSCs‑enriched spheroids, 
indicated by ability to serial sphere formation, significant up‑regulation of stemness genes, SOX2, C-MYC, NANOG and 
OCT4 in HT‑29 and SOX2, C-MYC and KLF4 in Caco‑2 spheroids (p-value < 0.05) and increased expression of CRC‑CSC 
markers compared to parental cells (p-value < 0.05). Additionally, HT‑29 spheroids exhibited a significant higher expres‑
sion of both ABCB1 and ABCG2 (p-value = 0.02). The significant up‑regulation of promoting EMT genes, ZEB1, TWIST1, 
E-cadherin and SNAIL1 in HT‑29 spheroids (p-value = 0.03), SNAIL1 and Vimentin in Caco‑2 spheroids (p-value < 0.05) 
and N-cadherin down‑regulation in both spheroids were observed.
Conclusion: Enrichment of CSC‑related features in HT‑29 and Caco‑2 (for the first time without applying special 
scaffold/biochemical) spheroids, suggests spheroid culture as robust, reproducible, simple and cost‑effective model 
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Background
Colorectal cancer (CRC) is the third most common can-
cer and the cause of cancer related-death in both men 
and women worldwide [1]. Although the effective ther-
apeutic interventions including surgery, chemo- and 
radiotherapy have improved the survival of patients with 
CRC, recurrence and metastasis are the main causes 
of CRC-related death [2]. There is accumulating evi-
dence that most solid tumors including CRC originate 
from tumor initiating or cancer stem cells (CSCs) [3–5]. 
CSCs are referred to as a sub-population of tumor cells 
with stem cell-like properties including self-renewal and 
multi-lineage differentiation capacity which are resistant 
to conventional therapies [6–9]. In fact, the emerging evi-
dence has shown that the deregulation of signaling path-
ways involved in self-renewal of normal stem cells leads 
to uncontrolled development of tumor cells along with 
functional and proliferative tumor heterogeneity [10].
Most of the challenges in cancer treatment such as 
treatment failure, tumor aggressiveness, relapse, metasta-
sis and poor prognosis are related to CSCs characteristic, 
most of which are attributed to epithelial to mesenchymal 
transition (EMT) potential, stemness signaling pathways 
regulating pluripotency, as well as the high expression 
of ATP-binding cassette (ABC) transporter genes in this 
subpopulation [11–18]. Hence, the complete regres-
sion of tumors requires identifying biological features of 
CSCs in in vitro and in vivo CSC models that may help 
to explore new approaches to target this subpopulation. 
There are several strategies of CSCs targeting including 
self-renewal prevention, altering drug permeability and 
stimulation of their differentiation [19–21]. Moreover, 
signal transduction pathways and microenvironmen-
tal signals in CSCs are considered the main therapeutic 
aspects linked to stem-cell biology that can be targeted 
[13, 22, 23].
Since it is difficult to fully identify the site of CSCs 
accumulation and monitor their distinct biological fea-
tures, the discovery and development of novel techniques 
for the isolation and evaluation of CSCs properties can 
play a significant role in the clinical diagnosis and treat-
ment of cancers. Different approaches have been applied 
to isolate, characterize, purify, and enrichment of CSCs 
from various cancers [7, 24]. Immunogenic characteris-
tics of CSCs, particularly as related to their specific cell 
surface markers such as CD133, ALDH1 and CD44, are 
the well-known methods which apply for CSCs isola-
tion and characterization in the early diagnosis and tar-
geted therapy of cancer [25], while methods such as 
sphere formation, clonogenic growth and drug resistance 
assays lead to functional isolation of CSCs [25].Thus, the 
development of feasible and applicable models for CSCs 
enrichment and assessment of its characteristics are war-
ranted. Cell-based assays including in  vitro cell culture, 
multicellular spheroids and organoid culture are valu-
able tools in obtaining information regarding cellular and 
molecular mechanisms involved in CSCs biology, and 
exploring new therapeutic strategies for targeting this 
sub-population [24, 26].
It is well accepted that micro tumor structures 
formed as spheroids present the main characteristics of 
in  vivo tumors such as cellular heterogeneity, hypoxia 
and pH rate, exposure to nutrients and metabolites, 
cell–cell cohesion and interaction, physical and chemi-
cal stresses, and gene expression profiles [27]. There-
fore, spheroids with their particular architecture and 
biology can serve as reliable cancer models in differ-
ent areas of cancer research, including tumor micro-
environment modeling and matrix remodeling as well 
as migration and invasion, drug discovery and screen-
ing, immune interactions and angiogenesis, etc. [26, 28, 
29]. There are different systems of spheroid formation, 
including suspension culture, non-adherent surface, 
hanging drop and microfluidic methods. Spheroids cul-
ture as serum free and non-adherent condition is the 
most frequent and powerful technique to obtain CSC-
like properties and expand CSCs. Moreover, the pres-
ence of mathematically testable approaches based on 
destruction of spheroids structure decreases underes-
timated results in clinical application and guarantees 
reproducibility [30, 31]. CRC cell lines have derived 
from different CRC subtypes and show different pho-
notypic and molecular properties in in vivo and in vitro 
studies [32, 33]. For example, despite similar epithelioid 
phenotypes of HT-29 and Caco-2 cells, HT-29 cells 
are invasive and metastatic in  vivo, but not in  vitro, 
whereas Caco-2 cells are noninvasive [34]. Moreover, 
the different cell lines can generate spheroids with dif-
ferences in morphological feature, as well as the capac-
ity of CSCs enrichment and CSC characteristics-related 
gene expression profiles. To overcome these limitations 
it is necessary to determine the ideal, most suitable cell 
to imitate the complexity of in vivo tumors including self‑renewal, drug resistance and invasion for in vitro research of 
CRC‑CSCs.
Keywords: Colorectal cancer (CRC), Cancer stem cells (CSCs), Sphere formation, Epithelial‑to‑mesenchymal transition 
(EMT), Drug resistance
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line for CSC studies both through evaluation and com-
parison of their-derived spheroids in terms of stem cell-
like characteristics.
Considering the aforementioned, this study aims to 
gain insight into the biological features of two different 
types of colonospheres, both derived from two colorec-
tal cancer cell lines including HT-29 and Caco-2 and 
assess whether these spheres are suitable models for CSC 
enrichment. Then, we evaluated the CSC-related charac-
teristics of generated spheroids in terms of gene expres-
sion profile and morphological features as compared 
to their parental cells in two-dimensional (2D) culture. 
Hence, we compared the expression level of genes, as 
related to the CSCs properties, including genes impli-
cated in stemness, EMT and drug resistance in HT-29 
and Caco-2 human colorectal carcinoma (CRC) cell lines 
grown in spheroids versus 2D cell culture conditions. We 
applied cost-effective, simple, and time-consuming meth-
ods for spheroid formation without using special scaffold 
or biochemical materials.
Materials and methods
Cell lines and culture conditions
HT-29 and Caco-2 human colon adenocarcinoma cell 
lines were obtained from the Iranian Biological Resource 
Center (IBRC, Tehran, Iran) and were tested for spheroid 
formation. Cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM)/High glucose medium (Gibco, 
Germany) supplemented with 10% fetal bovine serum 
(FBS, Gibco, Germany), 100 U/ml penicillin, 100  µg/
ml streptomycin antibiotics (Biowest, France), 1% non-
essential amino acid (Gibco, Germany) and 2 mM l-glu-
tamine (Gibco, Germany). Cultures were maintained 
under standard cell culture conditions in 37 °C, 5% CO2 
and 95% humidified incubator and passaged in 70–90% 
confluence.
Preparation of poly‑HEMA coated cell culture dishes
To prepare the 1.2% poly-HEMA (Poly-2-hydroxyethyl 
methacrylate) solution, 1.2 g poly-HEMA (Sigma, USA) 
was dissolved in 100  mL 96% ethanol by rotating over-
night to dissolve the polymers completely. The solution 
was centrifuged for 30 min at 400×g to remove unsolved 
particles and then filtered by 0.22  µm filters. The tissue 
culture dishes were coated with poly-HEMA solution 
(1.2 mL per each well of six well plate or 2.5 mL per T25 
tissue culture flask) under the biosafety laminar flow 
hood at room temperature for an overnight to evaporate 
ethanol completely. Finally, the plates were washed with 
phosphate buffer saline (PBS) and stored at 37 °C incuba-
tor for future use.
Spheroids culture
HT-29 and Caco-2 spheroids were generated by two 
types of spheroid culture systems; the hanging drop-
let technique or as free-floating spheroids cultured on 
poly-HEMA coated dishes. For hanging droplet sphe-
roids, the cells were detached with 0.05% trypsin/EDTA 
(Gibco, Germany) and after trypsin inactivation, the 
resulting single cells were washed twice with PBS and 
pre-warmed serum free media. Dissociated single cells 
re-suspended as five or ten thousand cells per 25μL of 
serum free medium (DMEM/F12, Gibco, Germany), 
which was supplemented with 20  ng/mL epidermal 
growth factor (EGF, PeproTech, USA), 10  ng/mL of 
basic fibroblast growth factor (bFGF, PeproTech, USA), 
2% B27 supplement (Gibco, Germany), 1% non-essen-
tial amino acid, 2  mM l-glutamine and 1% penicil-
lin–streptomycin. About 60 × 25μL cellular drops were 
dispensed on the inverted lids of the 9 cm petri dishes 
and the lids carefully set on the dishes, which had been 
pre-filled with five mL of PBS to assure high humidity 
and then incubated for 96 h. In the next step, the drop-
lets were washed with 2 mL of media by gentle shaking, 
and formed spheroids were transferred onto poly-
HEMA coated dishes for an additional 6 days. For free-
floating spheroids, single-cell suspensions were seeded 
into poly-HEMA coated dishes at different cell densi-
ties (1–5 ×  105 cells/mL) in the serum free medium as 
described above and were cultivated for up to 10 days. 
The culture media was supplemented with additional 
2% B27, bFGF and EGF every other day.
Secondary sphere formation assay
To examine the ability of colonospheres to form the 
next spheroid generations, spheroids were harvested 
and dissociated enzymatically with trypsin/EDTA and 
mechanically by gently pipetting. The resulting single 
cells, after counting, were re-plated in serum free sphe-
roid medium at the same densities and culture condi-
tions as mentioned above for three sequential passages 
(P1-P4).
Scanning electron microscopy
Spheroids were collected by centrifugation for 1 min at 
100  g and supernatant were carefully aspirated. Then, 
the collected spheroids were washed with PBS and 
fixed with 2.5% (v/v) glutaraldehyde in PBS for 30 min 
at room temperature. After fixation, spheroids were 
washed once with PBS and dehydrated using ethanol 
series (50, 65, 75, 85, and 100%). The samples were 
sputter-coated with gold–palladium and examined in 
scanning electron microscope (SEM, Seron Technol-
ogy, AIS-2100, Korea).
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Quantitative real‑time PCR analysis
The following genes were selected and examined 
by real-time PCR: stemness genes; KLF4, OCT4, 
SOX2, NANOG and C-MYC, EMT genes; Vimentin, 
SNAIL1,TWIST1, N-cadherin, E-cadherin and ZEB1, 
ABC transporter genes; ABCB1, ABCC1 and ABCG2. 
Spheroids were harvested a day before structural dis-
integration (day 10 for HT-29 and day 4 for Caco-2 
spheroids). The total RNAs were then extracted from 
parental and spheroid cells using RNeasy Mini Kit 
(Qiagen, Germany) according to the manufacturer’s 
instructions. After measurement of RNA quantity and 
quality by Nanodrop (ThermoFisher Scientific, USA), 
cDNA were synthesized with 1  μg of total RNA using 
cDNA synthesis kit (GeneAll, Korea). Real-time poly-
merase chain reaction (RT-qPCR) was performed 
using the SYBR Premix Ex Taq II real-time PCR kit 
(TaKaRa, Japan) on the Rotor-Gene Q LightCycler 
(Qiagene, Germany) with the following conditions: 40 
two-step amplification cycles of 95 °C for 5 s and 60 °C 
for 30  s. The relative expression values of target genes 
were quantified relative to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), as the internal reference 
gene, by using the  2−ΔCT method. Real-time PCR prim-
ers are listed in Table 1.
Flow cytometry
Flow cytometry was used to quantify the percentage of 
CSC markers expression in HT-29 and Caco-2 sphe-
roid cells compared to parental cells. The parental and 
spheroid cells from each cell line were dissociated with 
trypsin/EDTA and were washed with PBS twice. The 
dissociated cells were counted using Trypan blue exclu-
sion assay, and if cell viability was more than 95%, they 
were evaluated for CSC markers expression. The follow-
ing antibodies were used: anti-CD44 (1:30), anti-CD133 
(1:300), anti-CD166 (1:90) (all from abcam, USA). All 
antibodies were incubated with 3 ×  105 cells for 30 min at 
4 °C. Goat anti-rabbit IgG-FITC (1:100) (Santa Cruz bio-
technology, USA) was used as secondary antibody. The 
percentage of CSC marker positive cells were evaluated 
using an Atuune NxT flow cytometer (Thermo Fisher 
Scientific, USA) and data were analyzed using FlowJo VX 
software.
Statistical analysis
Data were reported as the mean ± standard deviation for 
each group from three or four independent experiments. 
The diameter of the spheroids was measured using Image 
J software (n = 25) (IJ 1.46r version, NIH, USA). Student’s 
t-test was used to compare the differences between the 
control (parental) and spheroid groups using GraphPad 
Prism version 8.0 for Windows (GraphPad Software, La 
Jolla, CA, USA, www. graph pad. com). A p-value < 0.05 
was accepted as a statistically significant difference 
between groups.
Results
HT‑29 and Caco‑2‑derived spheroids exhibit different 
spheroidization time and morphological characteristics
First, we tested whether HT-29 and Caco-2 cell lines 
(Fig.  1a, d) are able to generate three-dimensional (3D) 
spheroids. Spheroid formation in non-adherent condi-
tion on poly-HEMA coated dishes at different cell densi-
ties was applied for generation of spheroids from HT-29 
and Caco-2 adherent cells. Both cell lines could form 
spheroids, while HT-29 spheroids were unstable and 
the first signs of disintegration of their structure were 
observed 3  days after culture (data not shown). Hence, 
we used the hanging drop method as a well-established 
technique to spheroid formation from HT-29 cells. As 
observed from Fig. 1, both cell lines formed 3D spheroids 
in serum free media using the hanging drop method 
for HT-29 and free floating culture in non-adherent 
Table1 Primers used for quantitative RT‑PCR
Genes groups Gene name Primer Sequence (5´ → 3´)
Housekeeping gene GAPDH F‑CAT GAG AAG TAT GAC AAC AGCCT 
R‑AGT CCT TCC ACG ATA CCA AAGT 
Stemness genes C-MYC F‑ACA CAT CAG CAC AAC TAC G
R‑CGC CTC TTG ACA TTC TCC 
KLF4 F‑CCT CGC CTT ACA CAT GAA GAG 
R‑CAT CGG GAA GAC AGT GTG AAA 
SOX2 F‑AAT GGG AGG GGT GCA AAA GAGG 
R‑GTG AGT GTG GAT GGG ATT GGTG 
NANOG F‑AGC TAC AAA CAG GTG AAG AC
R‑GGT GGT AGG AAG AGT AAA GG
OCT4-A F‑GTG GAG AGC AAC TCC GAT G
R‑TGC AGA GCT TTG ATG TCC TG
EMT genes Vimentin F‑TCT ACG AGG AGG AGA TGC GG
R‑GGT CAA GAC GTG CCA GAG AC
SNAIL1 F‑CCA GAG TTT ACC TTC CAG CA
R‑GAT GAG CAT TGG CAG CGA 
TWIST1 F‑TTC TCG GTC TGG AGG ATG GA
R‑CCA CGC CCT GTT TCT TTG AAT 
N-cadherin F‑GCC CAA GAC AAA GAG ACC C
R‑CTG CTG ACT CCT TCA CTG AC
E-cadherin F‑CAG GAG TCA TCA GTG TGG T
R‑GGA GGA TTA TCG TTG GTG TCAG 
ZEB1 F‑CTT CTC ACA CTC TGG GTC TTA TTC 
R‑CGT TCT TCC GCT TCT CTC TTAC 
ABC Transporte ABCG2 F‑TTC CAC GAT ATG GAT TTA CGG 
R‑GTT TCC TGT TGC ATT GAG TCC 
ABCB1 F‑GTT CAG GTG GCT CTG GAT AAG 
R‑AGC GAT GAC GTC AGC ATT AC
ABCC1 F‑CGC CTT CGC TGA GTT CCT 
R‑TGC GGT GCT GTT GTG GTG 
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condition for Caco-2. Phase contrast microscope images 
from spheroids revealed different growth patterns; HT-29 
cells formed spheroids with round-type, smooth surface 
and compact morphology after 96 h incubation as hang-
ing drops and became more compact and dense during 
10  days of culture (Fig.  1b, c). By contrast, Caco-2 cells 
spontaneously started to form spheroids with round-
shape structure, and after cultivation for 3  days; they 
generated hollow spheroids with bubble-like structures 
(Fig.  1e, f ). Furthermore, the size of Caco-2 spheroids 
was significantly smaller than HT-29 spheroids after 
4  days of incubation (p-value < 0.01). The average diam-
eter of Caco-2 spheroids was 66.9 ± 14.88 µm compared 
to 82.52 ± 22.56 µm in HT-29 spheroids (Fig. 2).
However, Caco-2 cells exhibited shorter spheroidiza-
tion time; 2 days following plating compared to 4 days in 
HT-29, whereas HT-29 spheroids were more stable and 
maintained their compact spheroid architecture even up 
to 12  days of cultivation. In contrast, Caco-2 spheroids 
remained stable for 5  days. HT-29 spheroids showed 
greater increase in diameters over time than Caco-2 
spheroids. Whereas, the spheroids derived from Caco-2 
cells were slowly growing in size and displayed more sta-
ble diameter and less variability in size.
In order to assess spheroid morphological param-
eters in more detail and increase the spatial resolution, 
micrographs of spheroids were acquired by SEM. Both 
HT-29 and Caco-2 colonospheres showed continuous 
and smooth surfaces without any plasma membrane pro-
jections or microvilli so that it was hard to distinguish 
Fig. 1 Morphology of HT‑29 and Caco‑2 parental adherent monolayer cells and their derived spheroids. Representative phase contrast images from 
cell lines and their derived spheroids. a Parental HT‑29 cells grew as an adherent monolayer, b, c HT‑29 derived spheroids cultured at nonadherent 
and serum free condition showed well‑round shape and compact morphology. d Caco‑2 parental cells as monolayer and, e, f Caco‑2 derived 
spheroids displayed small and round shape morphology
Fig. 2 Size comparison of HT‑29 and Caco‑2 derived spheroids. 
Caco‑2 spheroids showed significantly smaller size in compared to 
HT‑29 spheroids. The average diameter of Caco‑2 spheroids was 
66.9 ± 14.88 µm compared to 82.52 ± 22.56 µm in HT‑29 spheroids. 
Data are presented as mean ± SD as ** = P < 0.01, (n = 25)
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individual cells (Fig.  3a, b). Interestingly, the hollow 
structures were observed in many of Caco-2 spheroids 
that were its obvious difference compared to HT-29 
spheroids with conglomerated appearance (Fig. 3a–c).
Enrichment of cancer stem cell‑like sub‑populations 
in generated spheroids
To investigate CSC enrichment in formed spheroids as 
compared to their adherent counterparts, we applied 
three separate techniques: (1) secondary sphere forma-
tion capacity whereby self-renewal properties of CSCs 
are exploited for maintaining stem-like features of can-
cer cells; (2) assessment of key stemness genes expres-
sion including SOX2, C-MYC, OCT4, KLF4 and NANOG, 
as master regulators of pluripotency and self-renewal 
capacity in CSCs; and (3) quantifying the expression of 
potential CSCs surface markers by flow cytometry.
A secondary sphere formation ability of generated 
spheroids was investigated by serial passaging. Seeding 
of single cells from early passage of spheroids showed 
that spheroids derived from both HT-29 and Caco-2 
cells still had the capacity to generate spheroids, even 
after four sub-cultures (Fig.  4a–h). Thus, these data 
suggest that spheroids maintain their self-renewal 
capacity over several passages. Furthermore, RT-qPCR 
analysis confirmed a definitive upregulation in most 
examined stem cell-related genes in both HT-29 and 
Caco-2 spheroids as compared to the 2D monolayers 
(Fig.  5a, b). HT-29 spheroids displayed the significant 
upregulation of SOX2, C-MYC, NANOG and OCT4 
(p-value < 0.03) stemness genes compared to HT-29 
parental cells with highest expression level of NANOG 
(p-value < 0.03) (Fig.  5a). Whereas, Caco-2 spheroids 
showed significant high expression of SOX2, C-MYC 
and KLF4 compared to Caco-2 parental cells with high-
est expression of SOX2 (p-value < 0.029) (Fig. 5b).
To further corroborate these findings, the expres-
sion of putative CSC surface markers CD166, CD44 
and CD133 were investigated. Similar to our observa-
tions from stemness genes expression analysis, flow 
cytometry analysis also revealed that the expression 
of CD166, CD44, CD133 CSC markers were elevated 
in both spheroid models compared to differentiated 
2D cultures which was statistically significant (CD166, 
CD44, CD133 (p-value < 0.03) in HT-29 spheroids and 
CD166 (p-value < 0.0008), CD44 (p-value < 0.0004) and 
CD133 (p-value < 0.03) in Caco-2 spheroids) (Fig. 6a, b) 
(Table 2).
CSC‑like enriched spheroids exhibited high expression 
of multi‑drug resistant (MDR) genes
Resistance against chemotherapeutics is another key 
feature of CSCs that is mediated by a family of ABC 
proteins. Accordingly, we assessed the expression pat-
tern of a panel of major multi-drug resistant (MDR) 
genes; ABCB1, ABCC1 and ABCG2 in generated sphe-
roids compared to parental cells. Specifically, HT-
29-derived spheroids exhibited a significant higher 
expression of both ABCB1 and ABCG2 compared to 
HT-29 parental cells (p-value = 0.02). The expression of 
ABCC1 was also increased in HT-29 derived spheroids 
than their parental cells, although this increase was not 
significant (p-value = 0.14) (Fig. 7a). In spite of the ABC 
expression pattern of HT-29 spheroids, Caco-2 sphe-
roids did not show any significant differences in expres-
sion patterns of ABCB1, ABCC1 and ABCG2 compared 
to Caco-2 parental cells (p-value > 0.99) (Fig. 7b).
Fig. 3 Scanning electron microscope (SEM) imaging of HT‑29 and Caco‑2 derived spheroids. SEM imaging was performed to assess spheroid 
morphological parameters in more details. Representative SEM images of spheroids shows roundness structure and smooth surfaces of both a 
Caco‑2 and b HT‑29 derived spheroids so that it is not possible to distinguish of individual cells. The hollow structures (arrows) in Caco‑2 spheroids 
is its obvious difference compared to HT‑29 spheroids with conglomerated appearance. c Representative phase contrast images of hollow core in 
Caco‑2 derived spheroids. Arrows indicate hollow core of Caco‑2 spheroids
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Fig. 4 Serial spheroid formation capacity of colonospheres. To evaluate the self‑renewal properties of generated spheroids, secondary spheroid 
formation was performed by serial passaging. Cells derived from a–f HT‑29 and e–h Caco‑2 spheroids generated spheroids for four consequence 
passage (P1–P4). There were no obvious differences in size and morphology of spheroids in different passages and their derived cells maintain their 
self‑renewal capacity over several passages
Page 8 of 16Gheytanchi et al. Cancer Cell Int          (2021) 21:204 
CRC spheroids were driven toward the EMT compared 
to 2D adherent cells
To characterize the EMT properties in generated sphe-
roids, we next compared the expression profile of EMT 
inducer genes including TWIST1, SNAIL1, ZEB1, Vimen-
tin, E-cadherin and N-cadherin in both spheroids and 
parental cells. The expression of EMT-promoting genes; 
ZEB1, TWIST1 and SNAIL1 were significantly up-reg-
ulated in HT-29 spheroids compared to 2D monolayer 
cultures (p-value = 0.03). Unexpectedly, the expres-
sion of E-cadherin was up-regulated in HT-29 sphe-
roids (Fig.  8a). A significant up-regulation of SNAIL1 
and Vimentin were also observed in Caco-2 spheroids 
than their parental cells (p-value < 0.05). Although ZEB1 
showed a higher expression in Caco-2 spheres than 2D 
counterparts, this upregulation was not statistically sig-
nificant (p-value > 0.05) (Fig.  8b). On the contrary, the 
expression of N-cadherin was down-regulated in both 
HT-29 and Caco-2 spheroids compared to parental cells 
(Fig. 8).
Discussion
To overcome the treatment failure due to the cancer 
recurrence and metastasis related to CSCs biological fea-
tures and their interference with intrinsic drug resistance 
mechanisms, design of appropriate preclinical models is 
one of the most pressing issues to test targeted therapies 
[35, 36]. Identification of the ideal tools to clarify CSC 
biology is still proceeding, and great efforts have been 
paid to improve the isolation and treatment modalities 
in CSCs research [37]. Spheres culture in which CSCs 
are trapped and enriched, has been recommended as an 
extremely effectual CSC isolation method for cancer cell 
lines and solid tumors [37–39]. Such an anchorage inde-
pendent sphere forming system under non-adherent, 
nutritional deficiency and serum free conditions pre-
vents the differentiation of stem-like cells and leads to 
eliminate non-CSCs cells through apoptosis [40–42]. The 
superiority of this method is based entirely on the intrin-
sic properties of CSCs and leads to enriching the CSC 
subpopulations regardless of the expression patterns of 
cell surface markers [43, 44]. Moreover, spheroid cultures 
offer an ideal platform for routine toxicity and drug effi-
cacy testing to determine safe exposure doses in designed 
cellular models [45–48]. In addition, previous studies 
have shown that different cancer cell lines form spheres 
with distinctive morphological and functional features 
based on sphere-formation method [49–51]. Hence, the 
status of morphological characteristics, CSC properties 
and genes expression profile of EMT and drug resistance 
is important in selecting appropriate model.
In this regard, in the current study, the forced floating 
using low attachment plates and hanging drop meth-
ods, as more applicable and feasible methods were used 
to generate CSC-enriched spheroids from Caco-2 and 
HT-29 cell lines, respectively. We chose these two cell 
lines because of their widespread use in research and 
Fig. 5 Increased expression of stemness regulator genes in HT‑29 and Caco‑2‑derived spheroids compared to adherent counterparts. a 
Quantitative real‑time PCR analysis of HT‑29 spheroids revealed the high expression of key stemness genes OCT4, SOX2, NANOG and C-MYC 
compared to HT‑29 parental cells with highest expression level of NANOG (p-value < 0.03). b Caco‑2 spheroids showed an increased expression 
of SOX2, C-MYC and KLF4 compared to Caco‑2 parental cells with highest expression of SOX2 (p-value < 0.029). Relative gene expression was 
evaluated following 10 and 4 days of culture for HT‑29 and Caco‑2 spheroids, respectively. Data are presented as mean ± SD from four independent 
experiments as * = P < 0.05, ns = not significant
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Fig. 6 Flow cytometry analysis of CRC‑CSC markers expression in HT‑29 and Caco‑2 spheroids compared to their parental cells. Representative flow 
cytometry plots confirmed both HT‑29 and Caco‑2 spheroids show higher expression of CD166, CD44 and CD133 CRC‑CSC markers as compared 
to their parental cells. Upregulation of CSC markers in spheroids as compared to their differentiated counterparts was predominant in Caco‑2 
spheroids than HT‑29 spheroids. Dot plots show the expression of each marker in one representative experiment
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drug discovery. The Caco-2 cell line is widely used in 
pre-clinical investigations, drug permeability and solubil-
ity studies and nanoparticle translocation. The cell line 
is accepted by the U.S. Food and Drug Administration 
(FDA) to support new drug applications. In addition both 
Caco-2 and HT-29 cells are widely applied in the studies 
of intestinal transport and prediction of bioavailability 
[52–54].
To generate spheroids, serum-free condition was 
applied to prevent the differentiation of stem-like cells 
and elimination of non-CSCs population using sus-
pension culturing in low attachment plates [55–58]. 
Although both cell lines showed capacity to form 
spheroids, the HT-29 cells generated loose and disin-
tegrating spheres in poly-HEMA plates, whereas, they 
formed compact spheroids when they were cultured as 
hanging drops. The comparison of morphological and 
molecular characteristics of Caco-2 and HT-29 derived 
spheroids has been summarized in Table 3.
Generation of dense and practical spheroids strongly 
depend on cellular interactions through the gap junc-
tions between single cells [59, 60]. Hence, hanging drop 
method was selected to generate HT-29 spheroids with 
compact structure due to its advantages in improve-
ment of cells accumulation and adhesion potential with 
least damage to the spheres through gravitational force. 
Our observation was in line with the previous study in 
rat pancreatic beta cells which hanging drop method 
enhanced connexin protein accumulation and genera-
tion of tight spheres [60]. Moreover, murine and human 
brain tumor cell lines showed more consistent structures 
in brain tumor spheroids with applying of hanging drop 
method compared to spinner culture [61]. Therefore, 
it seems that different cell lines can be compatible with 
different spheroid formation methods, as in our study 
as well; hanging drop and low attachment poly-HEMA 
coated plates were suitable, rapid and time efficient for 
spheroid formation from HT-29 and Caco-2 cells, respec-
tively. Some limitations of hanging drop including pos-
sible shattering of spheroids due to mechanical shock 
in transferring of spheroids to the conventional culture 
Table 2 The expression percentage of CD44, CD166, and CD133 
common CRC‑CSCs markers in spheroids compared to their 
parental cells
Data are shown as mean ± SD of four independent experiments. A significant 
upregulation of CSC markers in spheroids compared to parental cells are 
presented as * = P < 0.05, *** = P < 0.001, ns = not significant
Markers Cell types
HT‑29 Caco‑2
Parental Spheroid Parental Spheroid
CD44% 1.80 ± 0.77 19.3 ± 6.60* 1.59 ± 0.28 41.05 ± 3.53***
CD133% 1.35 ± 0.19 11.75 ± 4.69* 1.25 ± 0.45 28.25 ± 17.45*
CD166% 1.66 ± 0.37 22.40 ± 5.92* 1.78 ± 0.18 37.15 ± 4.02***
Fig. 7 The expression profile of drug resistance genes in HT‑29 and Caco‑2 derived spheroids compared to their adherent counterparts. The 
comparative real‑time PCR analysis of ABC transporter genes; ABCB1, ABCC1 and ABCG2 in generated spheroids and their parental cells showed 
a the higher expression of ABCB1 and ABCG2 in HT‑29 derived spheroids than HT‑29 parental cells, the expression of ABCC1 was also increased, 
although this increase was not significant (p‑value = 0.14), b whereas there was not observed significant differences between Caco‑2 spheroids and 
their parental cells. Data are presented as mean ± SD from four independent experiments as * = P < 0.05, ns = not significant
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plates and high spheroid-diameter variation compared 
to low attachment culture can lead to changes in initiat-
ing characteristics in HT-29 spheroids. Whereas, forced 
floating method using low attachment culture with more 
reproducibility than hanging drop could be the most suit-
able method for high-throughput screening. Therefore, 
Fig. 8 The expression profile of EMT regulator genes in HT‑29 and Caco‑2 derived spheroids compared to adherent counterparts. Graphs showing 
relative expression of genes involved in EMT; Vimentin, SNAIL1,TWIST1, N-cadherin, E-cadherin and ZEB1 in generated spheroids. a The expression of 
ZEB1, TWIST1, SNAIL1 and E-cadherin was significantly higher in HT‑29 spheroids than parental cells. b Caco‑2 spheroids showed higher expression 
of SNAIL1, Vimentin and E-cadherin compared to parental cells. Data are presented as *P < 0.05, ns = not significant
Table 3 The comparison of morphological and molecular characteristics of Caco‑2 and HT‑29‑derived spheroids
Characteristic Cell type
Caco‑2 HT‑29
Sphere formation method Free floating (suspension) culture Hanging drop method
Complexity of setup Simple (spontaneous formation) Moderate




Time consuming and exten‑
sive handling necessary
Spheroid formation rate (spheroidization time) 3 days 4 days
Spheroid structure maintenance Moderate (stable for 5 days) High (stable up to 12 days)
Morphological characteristics Round‑shape, hollow structures with bubble like 
structures
Round‑shape, smooth surface 
and compact morphology
Secondary sphere formation ability Yes Yes
Spheroid size (average) Medium (66.9 ± 14.88 µm) Large (82.52 ± 22.56 µm)
CSC enrichment capacity Yes Yes
Up‑regulated stemness genes SOX2, C-MYC, KLF4 SOX2, C-MYC, OCT4, NANOG
CSCs surface markers up‑regulation +  + + 
MDR genes up‑regulation No Yes
(ABCB1 and ABCG2)
Up‑regulated EMT genes SNAIL1, E-cadherin, Vimentin TWIST1, SNAIL1, ZEB1, 
E-cadherin
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appropriate cells and spheroid formation methods must 
be accurately chosen based on aim of study and tumor 
type.
Although both spheroids derived from HT-29 and 
Caco-2 cells exhibited similar roundness and smooth 
surfaces, the light and electron microscopic examination 
revealed some differences. The Caco-2 spheroids pre-
sented hollow core structure as a distinct morphologi-
cal feature which has been reported before by others [62, 
63]. Samy et al. [64], also found that after 5 days culturing 
in Matrigel, the Caco-2 cells self-organized into intestinal 
epithelial-like cells as spheroids with a confluent mon-
olayer surrounding a hollow lumen. This hollow structure 
in Caco-2 cells is account to the functional polarization 
through E-cadherin-dependent cell–cell adhesion [63, 
65]. Since the hollow core is the common feature of the 
Caco-2 spheres formed by different methods [62, 63], it 
can infer that this feature is cell line dependent and may 
not be related to the sphere formation methods.
The Caco-2 spheroids features including the expres-
sion of drug transporters similar to human intestinal 
and also their ability to recreate the spatial organization 
similar to intestinal epithelial cells have been made them 
as an improved platform in drug screening [64, 66, 67]. 
However, Caco-2 spheroids with round shape and hollow 
lumenized morphology have widely employed as a repro-
ducible in  vitro model for studying intestinal features 
and functions as well as intestinal drug metabolism and 
uptake [64, 68], they are not compatible with anti-cancer 
drug researches which are based on evaluation of the 
spheroid size reduction and drug penetration into inner 
layers. The roundness and smooth surface of spheroids 
which hide individual cells, is ascribed to high extracel-
lular microenvironment (ECM) secretion and strong 
cell–cell adhesion, and could help analysis of drugs 
efficacy more accurately [49, 69]. Accordingly, HT-29 
spheroids with compact round shape may be more suit-
able platforms for anti-cancer drug testing in CRC than 
Caco-2 spheres. In general, in order to create more prac-
tical and functional CRC spheroid models, it is essential 
to characterize the gene expression alterations, invasion, 
and drug transporters in spheroids to standardize them 
based on research requirements [61, 64, 70–72]. Hence, 
CRC spheroid models were further assessed to determine 
their potential in enrichment of CSCs-related character-
istics, including the cell surface marker patterns, serial 
sphere formation capability, and gene expression profiles 
of multipotency, EMT and drug resistance transporters 
compared to the parental cells. Our findings showed that 
the expression levels of stemness genes could be affected 
by CRC spheroid culture, and both spheroids displayed 
similar high expression levels of pluripotent stem cell 
genes (KLF4, OCT4 and C-MYC) when compared to 
their parental counterparts, while drastic higher expres-
sion level of SOX-2 and NANOG was found in Caco-2 
and HT-29 spheres, respectively. It has been also docu-
mented that the overexpression of NANOG as an onco-
gene along with OCT4 is a prominent characteristic of 
CSCs and is associated with EMT transition of CSCs and 
drives tumor progression and poor prognosis in patients 
with breast and colorectal cancer [73–78]. Furthermore, 
many studies have proved that SOX-2 overexpression is 
correlated with self-renewal capacity, a poorly differ-
entiated-aggressive phenotype and clinicopathological 
characteristics of CRC patients [79–81]. Therefore, high 
expression levels of stemness genes, specially, SOX2 and 
NANOG that were observed in our CRC spheroids could 
be served as an indicator of self-renewal potential.
We extended our study by assessing the expression of 
CSC surface markers in CRC spheroids compared to the 
parental cells. Our findings independently corroborated 
the expression profiles of stem cell-related genes which 
evidenced by enriching the CD166, CD44, CD133 posi-
tive populations of CSCs in CRC spheroids. This was in 
line with other reports in various cancers, where non-
adherent spheroid cultures possessed more character-
istics of CSCs [44, 82–85]. CD44 as a transmembrane 
adhesion receptor for hyaluronic acid, binds to the 
ECM and plays an important role in matrix adhesion in 
response to a cellular microenvironment and is impli-
cated in enhancing cellular aggregation [86, 87]. CD166 
and CD133 are also cell adhesion molecules which along 
with CD44 increase the clonal formation capacity in CRC 
and are related to CSC properties [85, 88]. The cell adhe-
sion proteins are participate in directing cell polarity 
and asymmetric stem cell division in development [89]. 
Although, there are limited studies on Caco-2 spheroids, 
we conclude that the higher expression of CD44, CD133 
and CD166 as robust CSC markers in cells derived from 
Caco-2 spheroid might be related to specific cellular 
junctions in these spheroids, which provide signals via 
molecular crosstalk between these cells for maintenance 
of CSC phenotype in Caco-2 spheroids. In addition, due 
to the absence of CSCs in necrotic core of spheroids 
[90], we assume that many of cells in HT-29 spheroids 
that were negative for expression of CSC markers may 
belong to this layer, whereas, in case of Caco-2 spheroids, 
there were hollow core instead of necrotic layer. Hence, 
this feature might account for predominant expression 
of CD44, CD166 and CD133 CSC markers observed 
in Caco-2 spheroid-derived cells as compared to cells 
derived from HT-29 spheroid.
Moreover, serial sphere formation which has been 
applied as an appropriate platform for long-term expan-
sion of cells with self-renewal capacity and imitates 
the tumor heterogeneity [24], was maintained in CRC 
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spheroids cells during the long-term cultures. Thus, these 
results further advocated the efficiency of the serum free 
and non-adherent condition in enrichment of CSCs. 
The complexity of cross-talks between stem cell–related 
genes and EMT are still unclear and need to be more 
clarified. To determine the association of the EMT genes 
expression level with the enriched CSC nature in sphe-
roids, we compared the expression of TWIST1, SNAIL1, 
ZEB1, Vimentin, E-cadherin and N-cadherin in sphe-
roids than parental cells. Our results showed that in 
spite of up-regulation of TWIST1, SNAIL1, ZEB1 and 
Vimentin, unexpectedly E-cadherin was up-regulated 
and N-cadherin was down-regulated in spheroids which 
are in contrast to the results of EMT process from other 
similar studies [91–94]. Several reports suggested the 
strong correlation of E-cadherin down-regulation and 
N-cadherin up-regulation as the main hallmark of EMT 
[76, 91–95]. It can be postulated that the expression level 
of EMT genes, might be varied widely due to the absence 
of definite correlation between the gene transcripts levels 
and their corresponding proteins and do not necessarily 
reflect their protein levels in CSCs [96–100]. In addition, 
Jolly, Jia et al. displayed that the partial EMT is associated 
with stemness [101]. Hence, deciphering the coupling of 
EMT and stemness needs to be further investigated.
The increased expression of ATP-binding cassette 
(ABC) transporter genes such as ABCB1, ABCC1, and 
ABCG2, as other CSC-related characteristic is involved 
in regulation of self-renewal and multidrug resistance in 
ovarian and colon cancer cell lines [102–107]. In agree-
ment with Collura et  al. [108], our results also demon-
strated significant increase in the expression of ABC B1 
and G2 genes in HT-29 spheres compared to monolay-
ers and Caco-2 spheres which further verified the CSCs 
enrichment.
Although the results of our study present robust and 
reproducible spheroid models for CSC research, these 
findings should be considered in the light of some limita-
tions, including evaluation of the spheroids of only two 
CRC cell lines and also performing additional functional 
analysis on metastatic capacity, ECM remodeling, chem-
oresistancy and dormancy. This information would pro-
vide new insight into the efficiency of the CRC spheroid 
model in CSC research.
Conclusions
In summary, we present here the first study demon-
strating CSC-enrichment in Caco-2 cells without using 
special scaffold or biochemical materials. Despite the 
hollow core structure and no increased expression of 
ABC transporter genes in Caco-2 spheroids, our findings 
indicated that spheroids culture from both HT-29 and 
Caco-2 cell lines is capable to enhance the expression of 
genes involved in CSCs regulation. It enables us to recre-
ate the complexity of in vivo tumors including presence 
of CSCs subpopulation, resistance to chemotherapeutics 
and invasion potential and should be considered as more 
realistic CRC in vitro models for further investigation in 
CSC research.
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